Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Keunchil Park

Publisher Correction: Comprehensive Molecular Characterization of Mitochondrial Genomes in Human Cancers

Nature Genetics

Genetics

2020

English

LUX-Lung 7: Is There Enough Data for a Final Conclusion? – Author's Reply

The Lancet Oncology

Oncology

2016

English

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

English

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and Its Clinical Implication

Journal of Thoracic Oncology

English

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results From a Randomized Phase 3 Study

Journal of Thoracic Oncology

English

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Journal of Thoracic Oncology

English

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Journal of Thoracic Oncology

English

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

English

Randomized Phase II Trial of Seribantumab in Combination With Erlotinib in Patients With EGFR Wild‐Type Non‐Small Cell Lung Cancer

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Keunchil Park

Publisher Correction: Comprehensive Molecular Characterization of Mitochondrial Genomes in Human Cancers

LUX-Lung 7: Is There Enough Data for a Final Conclusion? – Author's Reply

Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer

Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and Its Clinical Implication

First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients With Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results From a Randomized Phase 3 Study

A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21

Concurrent Genetic Alterations Predict the Progression to Target Therapy in EGFR-mutated Advanced Non-Small Cell Lung Cancer

Clinical Trial of Nintedanib in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck: A Multicenter Phase 2 Study (Korean Cancer Study Group HN14-01)

Randomized Phase II Trial of Seribantumab in Combination With Erlotinib in Patients With EGFR Wild‐Type Non‐Small Cell Lung Cancer